Montalbán, X., Gold, R., Thompson, A., Otero-Romero, S., Amato, M., Chandraratna, D., … Zipp, F. (2018). ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. European Journal of Neurology. https://doi.org/10.1111/ene.13536 (Original work published 2018)

Fernández, O., Delvecchio, M., Edan, G., Fredrikson, S., Giovannoni, G., Hartung, H., … Comi, G. (2018). Survey of diagnostic and treatment practices for multiple sclerosis in Europe, part 2: progressive MS, paediatric MS, pregnancy and general management. European Journal of Neurology. https://doi.org/10.1111/ene.13581 (Original work published 2018)

Chitnis, T., González, C., Healy, B., Saxena, S., Rosso, M., Barro, C., … Kuhle, J. (2018). Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis. Annals of Clinical and Translational Neurology, 5(12), 1478-1491. https://doi.org/10.1002/acn3.638

Hauser, S., Bar-Or, A., Cohen, J., Comi, G., Correale, J., Coyle, P., … Trial, G. A. I. and A. , II. (2020). Ofatumumab versus Teriflunomide in Multiple Sclerosis. The New England Journal of Medicine, 383(6), 546-557. https://doi.org/10.1056/NEJMoa1917246 (Original work published 2020)